000 01709 a2200433 4500
005 20250514001430.0
264 0 _c20010607
008 200106s 0 0 eng d
022 _a0360-3016
024 7 _a10.1016/s0360-3016(01)01479-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFrykholm, G J
245 0 0 _aCombined chemo- and radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum.
_h[electronic resource]
260 _bInternational journal of radiation oncology, biology, physics
_cJun 2001
300 _a427-34 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aCombined Modality Therapy
650 0 4 _aDisease-Free Survival
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aLeucovorin
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMethotrexate
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aRadiotherapy
_xadverse effects
650 0 4 _aRectal Neoplasms
_xdrug therapy
650 0 4 _aSurvival Rate
700 1 _aPÄhlman, L
700 1 _aGlimelius, B
773 0 _tInternational journal of radiation oncology, biology, physics
_gvol. 50
_gno. 2
_gp. 427-34
856 4 0 _uhttps://doi.org/10.1016/s0360-3016(01)01479-1
_zAvailable from publisher's website
999 _c11311527
_d11311527